April 2026
The global inactivated vaccines market size is estimated to hit around USD 79.02 billion by 2035 increasing from USD 45.44 billion in 2025, with a CAGR of 5.69%.
April 2026
The global meningococcal vaccine market size is estimated at USD 4.02 billion in 2025 and is predicted to increase from USD 4.28 billion in 2026 to approximately USD 6.91 billion by 2035, expanding at a CAGR of 5.57% from 2026 to 2035.
April 2026
The global vaccines market size was estimated at USD 91.97 billion in 2025 and is predicted to increase from USD 97.97 billion in 2026 to approximately USD 170.60 billion by 2035, expanding at a CAGR of 6.37% from 2026 to 2035.
March 2026
The global influenza vaccine market size is valued at USD 9.02 billion in 2025 and is predicted to increase from USD 9.73 billion in 2026 to approximately USD 19.19 billion by 2035, expanding at a CAGR of 7.84% from 2026 to 2035.
March 2026
The global vaccine contract manufacturing market size is valued at USD 4.72 billion in 2025 and is predicted to increase from USD 5.24 billion in 2026 to approximately USD 12.26 billion by 2034, expanding at a CAGR of 11.20% from 2025 to 2034.
March 2026
The global anthrax vaccine market size was evaluated at USD 14.18 billion in 2025 and is predicted to hit around USD 22.34 billion by 2035, growing at a CAGR of 4.65%.
March 2026
The global veterinary clostridium vaccine market size was evaluated at USD 908.96 billion in 2025 and is predicted to hit around USD 3,196.50 billion by 2035, growing at a CAGR of 13.40%.
March 2026
The global vaccine technologies market size is estimated to hit around USD 102.88 billion by 2035 increasing from USD 55.01 billion in 2025, with a CAGR of 6.46%.
February 2026
The global foot and mouth disease vaccine market size is expected to reach around USD 3.48 billion by 2035 from USD 1.94 billion in 2025 with a CAGR of 6.02%.
February 2026
The global respiratory disease vaccine market size was estimated at USD 101.10 billion in 2025 and is anticipated to reach around USD 123.77 billion by 2035, growing at a CAGR of 2.04% between 2026 to 2035.
February 2026
The global vaccine delivery devices market size was evaluated at USD 8.06 billion in 2025 and is predicted to hit around USD 17.10 billion by 2035, growing at a CAGR of 7.81%.
February 2026
The global adult vaccines market size was evaluated at USD 19.97 billion in 2025 and is predicted to hit around USD 50.39 billion by 2035, growing at a CAGR of 9.70%.
February 2026
The global pneumococcal vaccines market size was evaluated at 9.04 billion in 2025 and is predicted to hit around USD 16.68 billion by 2035, growing at a CAGR of 6.32%.
February 2026
The global canine vaccines market size was evaluated at USD 2.05 billion in 2025 and is predicted to hit around USD 4.23 billion by 2035, growing at a CAGR of 7.51%.
February 2026
The pediatric vaccines market size was valued at USD 66.41 billion in 2025 and is expected to attain around USD 117.32 billion by 2035 with a CAGR of 5.86%.
February 2026
The global brucellosis vaccines market size is valued at USD 266.78 million in 2025 and is expected to attain around USD 424.75 million by 2035 with a CAGR of 4.76%.
January 2026
The global human papillomavirus Hpv vaccines market size was evaluated at USD 9.73 billion in 2025 and is predicted to hit around USD 29.63 billion by 2035, growing at a CAGR of 11.78%.
January 2026
The global animal vaccine market size is calculated at USD 18.99 billion in 2025 and is predicted to increase from USD 20.89 billion in 2026 to approximately USD 48.62 billion by 2035, expanding at a CAGR of 9.86% from 2026 to 2035.
December 2025
The global live attenuated vaccines market size is estimated at USD 32.17 billion in 2025 and is expected to hit around USD 82.63 billion by 2034, with a CAGR of 11.05%.
November 2025
The global aquaculture vaccines market size is calculated at USD 553.40 million in 2025 and is projected to hit around USD 1,142.69 million by 2034 with a CAGR of 8.51% from 2025 to 2034.
November 2025
The global measles, mumps, rubella vaccine market size is estimated at USD 2.02 billion in 2025 and is expected to hit around USD 4.21 billion by 2034, growing at a CAGR of 8.51%.
November 2025
The mRNA vaccines and therapeutics market size reached USD 2.14 billion in 2025 and is projected to surpass around USD 1.63 billion by 2034 with a CAGR of 29.71%.
October 2025
The global feline vaccines market size is estimated to hit around USD 3.28 billion by 2034 increasing from USD 1.77 billion in 2025, with a CAGR of 7.12%.
October 2025
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 1,799.21 million by 2034, growing at a CAGR of 15.93%.
September 2025
The global infectious disease vaccines market size is estimated to hit around USD 72.40 billion by 2034 increasing from USD 36.25 billion in 2024, with a CAGR of 7.17%.
September 2025
The global vaccine CDMO market size was evaluated at USD 4.67 billion in 2024 and is predicted to hit around USD 11.16 billion by 2034, growing at a CAGR of 9.10%.
August 2025
The global oral vaccine market size was estimated at USD 3.87 billion in 2024 and is expected to surpass around USD 9.62 billion by 2034, with a CAGR of 9.53%.
August 2025
The global shingles vaccine market size was exhibited at USD 4.94 billion in 2024 and is predicted to attain around USD 20.57 billion by 2034, with a CAGR of 15.33%.
August 2025
The global vaccine adjuvants market size was estimated at USD 1.77 billion in 2025 and is projected to hit around USD 2.23 billion by 2035, with a CAGR of 2.34%.
June 2025
The global polio vaccine market size is estimated to hit around USD 1.7 billion by 2034 increasing from USD 1.14 billion in 2024, with a CAGR of 4.05%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com